Literature DB >> 7981955

Atherosclerosis and arterial influx of lipoproteins.

B G Nordestgaard1, L B Nielsen.   

Abstract

Accumulation of atherogenic lipoproteins in the arterial intima is a key event in the development of atherosclerosis. The likelihood of increased lipoprotein accumulation in the intima increases with increasing influx: arterial influx of lipoproteins is increased by increased arterial wall permeability, increased lipoprotein concentration in plasma, and by high blood pressure. On entrance into the arterial intima, lipoproteins can either efflux as intact particles, be retained in the intima, or be degraded by intimal cells. Increased degradation as well as increased retention of lipoproteins in the intima have both been associated with increased development of atherosclerosis. Therefore, low rates of efflux of intact particles, as appears to be the case for large particles like VLDL, IDL, and possibly lipoprotein (a) could potentially promote atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981955     DOI: 10.1097/00041433-199408000-00002

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  19 in total

Review 1.  Genetics of atherosclerosis: the search for genes acting at the level of the vessel wall.

Authors:  V Villa-Colinayo; W Shi; J Araujo; A J Lusis
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

Review 2.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 3.  The effect of n-3 fatty acids on low density lipoprotein subfractions.

Authors:  B A Griffin
Journal:  Lipids       Date:  2001       Impact factor: 1.880

Review 4.  Lipoprotein (a): a historical appraisal.

Authors:  Karam M Kostner; Gert M Kostner
Journal:  J Lipid Res       Date:  2016-11-07       Impact factor: 5.922

Review 5.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

Review 6.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

Review 7.  Susceptibility mutations for ischemic heart disease.

Authors:  B G Nordestgaard; A Tybjaerg-Hansen
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

8.  New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis.

Authors:  Michael Y Tsai; Brian T Steffen; Weihua Guan; Robyn L McClelland; Russell Warnick; Joseph McConnell; Daniel M Hoefner; Alan T Remaley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-14       Impact factor: 8.311

Review 9.  Demystifying the management of hypertriglyceridaemia.

Authors:  Gerald F Watts; Esther M M Ooi; Dick C Chan
Journal:  Nat Rev Cardiol       Date:  2013-09-24       Impact factor: 32.419

10.  Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study.

Authors:  Yashashwi Pokharel; Yuanyuan Tang; Bhaskar Bhardwaj; Krishna K Patel; Mohammed Qintar; James H O'Keefe; Krishnaji R Kulkarni; Peter H Jones; Seth S Martin; Salim S Virani; John A Spertus
Journal:  J Clin Lipidol       Date:  2017-10-03       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.